aspect of
expression)
→
CapableOf
→
show bevacizumab
| Typicality: | 0.250 |
| Saliency: | 0.000 |
| in rpe cells | 2 | location |
| result → show → bevacizumab | 3 |
| negative | neutral | positive |
| 0.026 | 0.917 | 0.056 |
| Raw frequency | 3 |
| Normalized frequency | 0.000 |
| Modifier score | 0.500 |
| Perplexity | 74.610 |